Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ABC transporters 💬 3 genes, 12 drugs (DrugBank) and 9 diseases |
ABCC8 1件: ABCC8 💬ABC transporters
|
Minoxidil Minoxidil 💬ABC transporters
| Minoxidil | 179 1件: 179 💬1. ABC transporters
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬2. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬2. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan potassium Losartan potassium 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬4. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬4. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
DRD2 1件: DRD2 💬Alcoholism
|
Buspirone hydrochloride Buspirone hydrochloride 💬Alcoholism
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
DRD2 1件: DRD2 💬Alcoholism
|
Buspirone Buspirone 💬Alcoholism
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
SLC6A3 1件: SLC6A3 💬Alcoholism
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Alcoholism
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬8. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
SLC6A3 1件: SLC6A3 💬Alcoholism
|
Methylphenidate Methylphenidate 💬Alcoholism
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬8. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan potassium Losartan potassium 💬Aldosterone synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬10. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬10. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 1件: SLC6A3 💬Amphetamine addiction
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Amphetamine addiction
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬12. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 1件: SLC6A3 💬Amphetamine addiction
|
Methylphenidate Methylphenidate 💬Amphetamine addiction
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬12. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Apelin signaling pathway 💬 20 genes, 36 drugs (DrugBank) and 77 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan potassium Losartan potassium 💬Apelin signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬14. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Apelin signaling pathway 💬 20 genes, 36 drugs (DrugBank) and 77 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬14. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan potassium Losartan potassium 💬Calcium signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬16. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬16. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
HRH1 1件: HRH1 💬Calcium signaling pathway
|
Clemastine fumarate Clemastine fumarate 💬Calcium signaling pathway
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
HRH1 1件: HRH1 💬Calcium signaling pathway
|
Clemastine Clemastine 💬Calcium signaling pathway
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
DRD2 2件: DRD2, HTR1 💬
|
Buspirone hydrochloride Buspirone hydrochloride 💬cAMP signaling pathway
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
DRD2 2件: DRD2, HTR1 💬
|
Buspirone Buspirone 💬cAMP signaling pathway
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan potassium Losartan potassium 💬cGMP-PKG signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬22. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬22. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
DRD2 1件: DRD2 💬Cocaine addiction
|
Buspirone hydrochloride Buspirone hydrochloride 💬Cocaine addiction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
DRD2 1件: DRD2 💬Cocaine addiction
|
Buspirone Buspirone 💬Cocaine addiction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
SLC6A3 1件: SLC6A3 💬Cocaine addiction
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Cocaine addiction
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬26. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
SLC6A3 1件: SLC6A3 💬Cocaine addiction
|
Methylphenidate Methylphenidate 💬Cocaine addiction
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬26. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease - COVID-19
|
Losartan potassium Losartan potassium 💬Coronavirus disease - COVID-19
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬28. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease - COVID-19
|
Losartan Losartan 💬Coronavirus disease - COVID-19
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬28. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan potassium Losartan potassium 💬Cortisol synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬30. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬30. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan potassium Losartan potassium 💬Cushing syndrome
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬32. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬32. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan potassium Losartan potassium 💬Diabetic cardiomyopathy
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬34. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬34. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
DRD2 1件: DRD2 💬Dopaminergic synapse
|
Buspirone hydrochloride Buspirone hydrochloride 💬Dopaminergic synapse
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
DRD2 1件: DRD2 💬Dopaminergic synapse
|
Buspirone Buspirone 💬Dopaminergic synapse
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
SLC6A3 1件: SLC6A3 💬Dopaminergic synapse
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Dopaminergic synapse
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬38. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
SLC6A3 1件: SLC6A3 💬Dopaminergic synapse
|
Methylphenidate Methylphenidate 💬Dopaminergic synapse
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬38. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
DRD2 1件: DRD2 💬Gap junction
|
Buspirone hydrochloride Buspirone hydrochloride 💬Gap junction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
DRD2 1件: DRD2 💬Gap junction
|
Buspirone Buspirone 💬Gap junction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
KCNJ11 1件: KCNJ11 💬GnRH secretion
|
Minoxidil Minoxidil 💬GnRH secretion
| Minoxidil | 179 1件: 179 💬42. GnRH secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan potassium Losartan potassium 💬Hormone signaling
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬43. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan Losartan 💬Hormone signaling
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬43. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
DRD2 1件: DRD2 💬Hormone signaling
|
Buspirone hydrochloride Buspirone hydrochloride 💬Hormone signaling
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
DRD2 1件: DRD2 💬Hormone signaling
|
Buspirone Buspirone 💬Hormone signaling
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
HRH1 1件: HRH1 💬Inflammatory mediator regulation of TRP channels
|
Clemastine fumarate Clemastine fumarate 💬Inflammatory mediator regulation of TRP channels
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
HRH1 1件: HRH1 💬Inflammatory mediator regulation of TRP channels
|
Clemastine Clemastine 💬Inflammatory mediator regulation of TRP channels
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
ABCC8 2件: ABCC8, KCNJ11 💬
|
Minoxidil Minoxidil 💬Insulin secretion
| Minoxidil | 179 1件: 179 💬49. Insulin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
DRD2 2件: DRD2, HTR1 💬
|
Buspirone hydrochloride Buspirone hydrochloride 💬Neuroactive ligand signaling
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
DRD2 2件: DRD2, HTR1 💬
|
Buspirone Buspirone 💬Neuroactive ligand signaling
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
HRH1 1件: HRH1 💬Neuroactive ligand signaling
|
Clemastine fumarate Clemastine fumarate 💬Neuroactive ligand signaling
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
HRH1 1件: HRH1 💬Neuroactive ligand signaling
|
Clemastine Clemastine 💬Neuroactive ligand signaling
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Neuroactive ligand signaling
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬54. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Methylphenidate Methylphenidate 💬Neuroactive ligand signaling
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬54. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan potassium Losartan potassium 💬Neuroactive ligand-receptor interaction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬56. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬56. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
DRD2 2件: DRD2, HTR1 💬
|
Buspirone hydrochloride Buspirone hydrochloride 💬Neuroactive ligand-receptor interaction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
DRD2 2件: DRD2, HTR1 💬
|
Buspirone Buspirone 💬Neuroactive ligand-receptor interaction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
HRH1 1件: HRH1 💬Neuroactive ligand-receptor interaction
|
Clemastine fumarate Clemastine fumarate 💬Neuroactive ligand-receptor interaction
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
HRH1 1件: HRH1 💬Neuroactive ligand-receptor interaction
|
Clemastine Clemastine 💬Neuroactive ligand-receptor interaction
| Clemastine | 013 2件: 13, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
DRD2 1件: DRD2 💬Parkinson disease
|
Buspirone hydrochloride Buspirone hydrochloride 💬Parkinson disease
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
DRD2 1件: DRD2 💬Parkinson disease
|
Buspirone Buspirone 💬Parkinson disease
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
SLC6A3 1件: SLC6A3 💬Parkinson disease
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Parkinson disease
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬64. Parkinson disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
SLC6A3 1件: SLC6A3 💬Parkinson disease
|
Methylphenidate Methylphenidate 💬Parkinson disease
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬64. Parkinson disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan potassium Losartan potassium 💬Pathways in cancer
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬66. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬66. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
SLC6A3 1件: SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬68. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
SLC6A3 1件: SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Methylphenidate Methylphenidate 💬Pathways of neurodegeneration - multiple diseases
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬68. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan potassium Losartan potassium 💬Phospholipase D signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬70. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬70. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
DRD2 1件: DRD2 💬Rap1 signaling pathway
|
Buspirone hydrochloride Buspirone hydrochloride 💬Rap1 signaling pathway
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
DRD2 1件: DRD2 💬Rap1 signaling pathway
|
Buspirone Buspirone 💬Rap1 signaling pathway
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan potassium Losartan potassium 💬Renin secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬74. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬74. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan potassium Losartan potassium 💬Renin-angiotensin system
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬76. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬76. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
HTR1 1件: HTR1 💬Serotonergic synapse
|
Buspirone hydrochloride Buspirone hydrochloride 💬Serotonergic synapse
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
HTR1 1件: HTR1 💬Serotonergic synapse
|
Buspirone Buspirone 💬Serotonergic synapse
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Methylphenidate hydrochloride Methylphenidate hydrochloride 💬Synaptic vesicle cycle
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬80. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Methylphenidate Methylphenidate 💬Synaptic vesicle cycle
| Methylphenidate | 006 7件: 6 , 13, 34, 84, 113, 179, 206 💬80. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
HTR1 1件: HTR1 💬Taste transduction
|
Buspirone hydrochloride Buspirone hydrochloride 💬Taste transduction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
HTR1 1件: HTR1 💬Taste transduction
|
Buspirone Buspirone 💬Taste transduction
| Buspirone | 006 3件: 6 , 51, 179 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
ABCC8 2件: ABCC8, KCNJ11 💬
|
Minoxidil Minoxidil 💬Type II diabetes mellitus
| Minoxidil | 179 1件: 179 💬84. Type II diabetes mellitus
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan potassium Losartan potassium 💬Vascular smooth muscle contraction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬85. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬85. Vascular smooth muscle contraction
|
ABC transporters
3 genes, 12 drugs (DrugBank) and 9 diseases
Adrenergic signaling in cardiomyocytes
31 genes, 84 drugs (DrugBank) and 76 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Alcoholism
29 genes, 81 drugs (DrugBank) and 60 diseases
Aldosterone synthesis and secretion
20 genes, 41 drugs (DrugBank) and 61 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Apelin signaling pathway
20 genes, 36 drugs (DrugBank) and 77 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Cocaine addiction
15 genes, 66 drugs (DrugBank) and 54 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cortisol synthesis and secretion
15 genes, 36 drugs (DrugBank) and 63 diseases
Cushing syndrome
24 genes, 55 drugs (DrugBank) and 71 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
GnRH secretion
22 genes, 47 drugs (DrugBank) and 56 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Inflammatory mediator regulation of TRP channels
25 genes, 53 drugs (DrugBank) and 65 diseases
Insulin secretion
15 genes, 48 drugs (DrugBank) and 51 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
Parkinson disease
24 genes, 76 drugs (DrugBank) and 68 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Renin-angiotensin system
6 genes, 21 drugs (DrugBank) and 32 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Synaptic vesicle cycle
8 genes, 34 drugs (DrugBank) and 42 diseases
Taste transduction
28 genes, 91 drugs (DrugBank) and 68 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
Vascular smooth muscle contraction
32 genes, 92 drugs (DrugBank) and 71 diseases